InsiderTrades.com logo
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
From Colonial Metals   |   Ad
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold.
Ivor Macleod net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Ivor Macleod Biography and Net Worth

CFO of Athersys

Mr. Macleod has served as our Chief Financial Officer since late January 2020. He has over three decades of experience across all aspects of the life sciences value chain from basic research to commercialization both in Europe and the U.S. Prior to joining Athersys, Mr. Macleod served as Chief Financial Officer and Chief Compliance Officer at Eisai Inc., the U.S. subsidiary of the Japanese company Eisai Ltd. He has held key financial leadership positions at Merck and Co., Boehringer Mannheim Therapeutics and F. Hoffmann-La Roche where he served as Chief Financial Officer of North America for ten years. Mr. Macleod holds a Bachelor of Science from the University of St. Andrews in Scotland, an MBA from the University of Arizona and is a Certified Public Accountant (CPA), licensed in Virginia.

How do I contact Ivor Macleod?

The corporate mailing address for Mr. Macleod and other Athersys executives is 3201 CARNEGIE AVENUE, CLEVELAND OH, 44115. Athersys can also be reached via phone at (216) 431-9900 and via email at [email protected]. Learn More on Ivor Macleod's contact information.

Has Ivor Macleod been buying or selling shares of Athersys?

Ivor Macleod has not been actively trading shares of Athersys during the last quarter. Most recently, on Wednesday, November 17th, Ivor Macleod bought 15,000 shares of Athersys stock. The stock was acquired at an average cost of $1.18 per share, with a total value of $17,700.00. Learn More on Ivor Macleod's trading history.

Who are Athersys' active insiders?

Athersys' insider roster includes Laura Campbell (Insider), John Harrington (EVP), Ismail Kola (Director), William Lehmann, Jr. (CEO), and Ivor Macleod (CFO). Learn More on Athersys' active insiders.

Ivor Macleod Insider Trading History at Athersys

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2021Buy15,000$1.18$17,700.00View SEC Filing Icon  
See Full Table

Ivor Macleod Buying and Selling Activity at Athersys

This chart shows Ivor Macleod's buying and selling at Athersys by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Athersys Company Overview

Athersys logo
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio.
Read More

Today's Range

Now: $0.00
Low: $0.00
High: $0.00

50 Day Range

MA: $0.01
Low: $0.00
High: $0.02

2 Week Range

Now: $0.00
Low: $0.01
High: $1.99

Volume

233,798 shs

Average Volume

1,765,480 shs

Market Capitalization

$271,563.60

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
From Colonial Metals   |   Ad
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold.